These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 33381542)

  • 1. Corrigendum to "The SLC Family Are Candidate Diagnostic and Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma".
    Kang W; Zhang M; Wang Q; Gu D; Huang Z; Wang H; Xiang Y; Xia Q; Cui Z; Jin X
    Biomed Res Int; 2020; 2020():1025178. PubMed ID: 33381542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SLC Family Are Candidate Diagnostic and Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma.
    Kang W; Zhang M; Wang Q; Gu D; Huang Z; Wang H; Xiang Y; Xia Q; Cui Z; Jin X
    Biomed Res Int; 2020; 2020():1932948. PubMed ID: 32461965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum to "Cell Cycle Genes Are Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma".
    Liping X; Jia L; Qi C; Lian Y; Dongen L; Jianshuai J
    Biomed Res Int; 2020; 2020():8679532. PubMed ID: 33354571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum to "ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma".
    Wang T; Zhong H; Qin Y; Wei W; Li Z; Huang M; Luo X
    Biomed Res Int; 2021; 2021():3179693. PubMed ID: 33644226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Corrigendum: Urothelial carcinoma involving the renal calyce revealed due to brain metastasis].
    Pan African Medical Journal
    Pan Afr Med J; 2020; 36():50. PubMed ID: 32582405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum to "Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively".
    Yu Q; Xu C; Yuan W; Wang C; Zhao P; Chen L; Ma J
    Biomed Res Int; 2018; 2018():3782512. PubMed ID: 30258849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corrigendum: STAM Prolongs Clear Cell Renal Cell Carcinoma Patients' Survival
    Deng T; He Z; Duan X; Gu D; Cai C; Wu W; Liu Y; Zeng G
    Front Oncol; 2021; 11():726290. PubMed ID: 34568056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum: CDT1 is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma.
    Cai C; Zhang Y; Hu X; Hu W; Yang S; Qiu H; Chu T
    Front Oncol; 2021; 11():801970. PubMed ID: 34900749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrigendum: Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma.
    Yao Y; Wang Y; Wu D; Hu B
    Front Oncol; 2021; 11():731942. PubMed ID: 34368004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrigendum: A New Prognostic Risk Score: Based on the Analysis of Autophagy-Related Genes and Renal Cell Carcinoma.
    He M; Li M; Guan Y; Wan Z; Tian J; Xu F; Zhou H; Gao M; Bi H; Chong T
    Front Genet; 2022; 13():904512. PubMed ID: 35860474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corrigendum: Identification of Mitochondrial-Related Prognostic Biomarkers Associated With Primary Bile Acid Biosynthesis and Tumor Microenvironment of Hepatocellular Carcinoma.
    Zhang T; Nie Y; Gu J; Cai K; Chen X; Li H; Wang J
    Front Oncol; 2021; 11():843623. PubMed ID: 35111689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corrigendum to "Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study)".
    Ther Adv Med Oncol; 2021; 13():17588359211036552. PubMed ID: 34824634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and prognostic value of scavenger receptor class B type 1 in clear cell renal cell carcinoma.
    Xu G; Lou N; Xu Y; Shi H; Ruan H; Xiao W; Liu L; Xiao H; Qiu B; Bao L; Yuan C; Chen K; Yang H; Zhang X
    Tumour Biol; 2017 May; 39(5):1010428317699110. PubMed ID: 28466781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis the prognostic values of solute carrier (SLC) family 39 genes in gastric cancer.
    Ding B; Lou W; Xu L; Li R; Fan W
    Am J Transl Res; 2019; 11(1):486-498. PubMed ID: 30788004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum to "Metastatic Renal Cell Carcinoma Presenting as Prolonged Pyrexia and Stauffer's Syndrome: Can a Routine Ultrasound Scan Fail to Detect a Renal Cell Carcinoma?".
    Fonseka CL; Kariyawasam AGTA; Singhapura SDAL; de Silva CM; Kanakkahewa TE; Senarathna IGTM; Bodinayake CK
    Case Rep Radiol; 2018; 2018():6852737. PubMed ID: 30510830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrigendum to "Pazopanib in the treatment of advanced renal cell carcinoma" by David Cella and Jennifer L. Beaumont,
    Ther Adv Urol; 2016 Aug; 8(4):291. PubMed ID: 27928431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.
    Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X
    Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corrigendum to "Collision Tumor With Renal Cell Carcinoma and Plasmacytoma: Further Evidence of a Renal Cell and Plasma Cell Neoplasm Relationship?" [Urology Case Reports 6 (2017) 50-52].
    Berquist SW; Hassan AS; Miakicheva O; Dufour C; Hamilton Z; Shabaik A; Derweesh IH
    Urol Case Rep; 2017 Jul; 13():165. PubMed ID: 29541578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corrigendum: Cyclooxygenase-2 and β-Catenin as Potential Diagnostic and Prognostic Markers in Endometrial Cancer.
    Deng L; Liang H; Han Y
    Front Oncol; 2020; 10():582704. PubMed ID: 33224882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma.
    Kroeze SG; Bijenhof AM; Bosch JL; Jans JJ
    Cancer Biomark; 2010; 7(6):261-8. PubMed ID: 21694464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.